356 related articles for article (PubMed ID: 9685210)
1. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor.
Quelle FW; Thierfelder W; Witthuhn BA; Tang B; Cohen S; Ihle JN
J Biol Chem; 1995 Sep; 270(35):20775-80. PubMed ID: 7657660
[TBL] [Abstract][Full Text] [Related]
3. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
6. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
7. In vitro activation of Stat3 by epidermal growth factor receptor kinase.
Park OK; Schaefer TS; Nathans D
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13704-8. PubMed ID: 8942998
[TBL] [Abstract][Full Text] [Related]
8. The functional role of the JAK-STAT pathway in post-infarction remodeling.
El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
[TBL] [Abstract][Full Text] [Related]
9. Specific DNA binding and transactivation potential of recombinant, purified Stat5.
Beisenherz-Huss C; Mundt M; Herrala A; Vihko P; Schubert A; Groner B
Mol Cell Endocrinol; 2001 Oct; 183(1-2):101-12. PubMed ID: 11604230
[TBL] [Abstract][Full Text] [Related]
10. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
[TBL] [Abstract][Full Text] [Related]
11. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT).
Schwaiger FW; Hager G; Schmitt AB; Horvat A; Hager G; Streif R; Spitzer C; Gamal S; Breuer S; Brook GA; Nacimiento W; Kreutzberg GW
Eur J Neurosci; 2000 Apr; 12(4):1165-76. PubMed ID: 10762348
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
13. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.
Wood TJ; Sliva D; Lobie PE; Goullieux F; Mui AL; Groner B; Norstedt G; Haldosén LA
Mol Cell Endocrinol; 1997 Jun; 130(1-2):69-81. PubMed ID: 9220023
[TBL] [Abstract][Full Text] [Related]
14. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
[TBL] [Abstract][Full Text] [Related]
16. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
Le MN; Kohanski RA; Wang LH; Sadowski HB
Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
18. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]